| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Departments of Thoracic/Head and Neck Medical Oncology [W. W., W. K. H., L. M.] and Pathology [B. L. K.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, and Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center, Dallas, Texas 75235 [M. L. P., A. E. G., J. D. M.]
DMBT1 is a candidate tumor suppressor gene located at 10q25.3–26.1. Homozygous deletion of the gene was found in a subset of medulloblastoma and glioblastoma multiforme; lack of expression was noted in the majority of these tumors. In adult tissues, DMBT1 is highly expressed only in lung and small intestine tissues, indicating its important role in these organs. By analyzing lung cancer cell lines and primary lung tumors using reverse transcription-PCR, we found that 100% (20 of 20) of small cell lung cancer (SCLC) cell lines and 43% (6 of 14) of non-small cell lung cancer (NSCLC) cell lines lacked DMBT1 expression. Furthermore, 45% (9 of 20) of the primary NSCLCs exhibited a markedly low level of gene expression compared with corresponding normal lung tissues, indicating that lack of gene expression also occurs in primary lung cancers. To determine the potential mechanisms for lack of DMBT1 expression in lung cancer, we analyzed tumor cell lines for potential intragenic homozygous deletions of the gene and found such homozygous deletions in 10% (4 of 40) of SCLC cell lines but in none of 14 NSCLC cell lines. Moreover, the loss of expression could not be rescued by treatment with a demethylation agent (5-azacytidine) in two NSCLC cell lines lacking DMBT1 expression, suggesting that de novo methylation of the promoter region of the gene is unlikely to play a role in inactivation of the gene. We then sequenced the whole coding region of DMBT1 in 8 NSCLC cell lines that expressed DMBT1 and 20 primary NSCLCs. A potential point mutation at codon 52 was detected in a NSCLC cell line and resulted in an amino acid change from serine to tryptophan. Three common polymorphisms were also detected in tissues analyzed. Our data demonstrate that DMBT1 expression is frequently lost in lung cancer due to gene deletion and to other not yet identified mechanisms, suggesting that inactivation of DMBT1 may play an important role in lung tumorigenesis.
This article has been cited by other articles:
|
|
 |
|
  A. C. Blackburn, L. Z. Hill, A. L. Roberts, J. Wang, D. Aud, J. Jung, T. Nikolcheva, J. Allard, G. Peltz, C. N. Otis, et al. Genetic Mapping in Mice Identifies DMBT1 as a Candidate Modifier of Mammary Tumors and Breast Cancer Risk Am. J. Pathol., June 1, 2007; 170(6): 2030 - 2041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ghosh and G. J. Duigou Decreased Replication Ability of E1-Deleted Adenoviruses Correlates with Increased Brain Tumor Malignancy Cancer Res., October 1, 2005; 65(19): 8936 - 8943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Kang, O. Nielsen, C. Fenger, G. Leslie, U. Holmskov, and K. B.M. Reid Induction of DMBT1 expression by reduced ERK activity during a gastric mucosa differentiation-like process and its association with human gastric cancer Carcinogenesis, June 1, 2005; 26(6): 1129 - 1137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Meuwissen and A. Berns Mouse models for human lung cancer Genes & Dev., March 15, 2005; 19(6): 643 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tynan, E. Pacia, D. Haynes-Johnson, D. Lawrence, M. R. D'Andrea, J.-Z. Guo, S. Lundeen, and G. Allan The Putative Tumor Suppressor Deleted in Malignant Brain Tumors 1 Is an Estrogen-Regulated Gene in Rodent and Primate Endometrial Epithelium Endocrinology, March 1, 2005; 146(3): 1066 - 1073. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.J. Bikker, J.E. van der Wal, A.J.M. Ligtenberg, J. Mollenhauer, J.M.A. de Blieck-Hogervorst, I. van der Waal, A. Poustka, and A.V. Nieuw Amerongen Salivary Agglutinin/DMBT1SAG Expression is Up-regulated in the Presence of Salivary Gland Tumors J. Dent. Res., July 1, 2004; 83(7): 567 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Z. Kristiansen, J. Bunkenborg, M. Gronborg, H. Molina, P. J. Thuluvath, P. Argani, M. G. Goggins, A. Maitra, and A. Pandey A Proteomic Analysis of Human Bile Mol. Cell. Proteomics, July 1, 2004; 3(7): 715 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Al-Awqati, S. Vijayakumar, and J. Takito Terminal Differentiation of Epithelia from Trophectoderm to the Intercalated Cell: The Role of Hensin J. Am. Soc. Nephrol., June 1, 2003; 14(90001): S16 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sasaki, R. A. Betensky, J. G. Cairncross, and D. N. Louis DMBT1 Polymorphisms: Relationship to Malignant Glioma Tumorigenesis Cancer Res., March 1, 2002; 62(6): 1790 - 1796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.J. Bikker, A.J.M. Ligtenberg, J.E. van der Wal, P.A.M. van den Keijbus, U. Holmskov, E.C.I. Veerman, and A.V. Nieuw Amerongen Immunohistochemical Detection of Salivary Agglutinin/gp-340 in Human Parotid, Submandibular, and Labial Salivary Glands J. Dent. Res., February 1, 2002; 81(2): 134 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mollenhauer, S. Herbertz, B. Helmke, G. Kollender, I. Krebs, J. Madsen, U. Holmskov, K. Sorger, L. Schmitt, S. Wiemann, et al. Deleted in Malignant Brain Tumors 1 Is a Versatile Mucin-like Molecule Likely to Play a Differential Role in Digestive Tract Cancer Cancer Res., December 1, 2001; 61(24): 8880 - 8886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sasaki, M. C. Zlatescu, R. A. Betensky, Y. Ino, J. G. Cairncross, and D. N. Louis PTEN Is a Target of Chromosome 10q Loss in Anaplastic Oligodendrogliomas and PTEN Alterations Are Associated with Poor Prognosis Am. J. Pathol., July 1, 2001; 159(1): 359 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hikita, S. Vijayakumar, J. Takito, H. Erdjument-Bromage, P. Tempst, and Q. Al-Awqati Induction of Terminal Differentiation in Epithelial Cells Requires Polymerization of Hensin by Galectin 3 J. Cell Biol., December 11, 2000; 151(6): 1235 - 1246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-X. Liu, S. Musco, N. M. Lisitsina, E. Forgacs, J. D. Minna, and N. A. Lisitsyn LRP-DIT, a Putative Endocytic Receptor Gene, Is Frequently Inactivated in Non-Small Cell Lung Cancer Cell Lines Cancer Res., April 1, 2000; 60(7): 1961 - 1967. [Abstract] [Full Text]
|
|
|
|
|
|
J. Mollenhauer, S. Herbertz, U. Holmskov, M. Tolnay, I. Krebs, A. Merlo, H. D. Schrøder, D. Maier, F. Breitling, S. Wiemann, et al. DMBT1 Encodes a Protein Involved in the Immune Defense and in Epithelial Differentiation and Is Highly Unstable in Cancer Cancer Res., March 1, 2000; 60(6): 1704 - 1710. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. M. Fong, Y. Sekido, and J. D. Minna MOLECULAR PATHOGENESIS OF LUNG CANCER J. Thorac. Cardiovasc. Surg., December 1, 1999; 118(6): 1136 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Holmskov, J. Mollenhauer, J. Madsen, L. Vitved, J. Gronlund, I. Tornoe, A. Kliem, K. B. M. Reid, A. Poustka, and K. Skjodt Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D PNAS, September 14, 1999; 96(19): 10794 - 10799. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
